UBC Okanagan researchers have advanced their work on developing a non-invasive, accessible way to reduce uncontrolled hand ...

Huntington's disease symptom control relies on medications for involuntary movements, mood, and psychiatric symptoms, but ...

Researchers at the University of British Columbia Okanagan have developed a new wearable device designed to help people ...

When we think of movement disorders, the tremors associated with Parkinson’s disease are probably what first spring to mind. However, there are other equally debilitating and much less well-known ...

Celon Pharma’s PDE10A inhibitor has reduced involuntary movements in a phase 2 trial of individuals with Parkinson’s disease. The Polish biotech tested two daily doses of the drug, dubbed CPL’36, in ...

Transcranial direct current stimulation (tDCS) may be an effective and safe treatment for improving the facial-oral motor symptoms of tardive dyskinesia (TD) in chronically hospitalized patients with ...

Athetosis and chorea are two types of involuntary movements that can occur in children and adults with neurological conditions, such as cerebral palsy. The movements have different features, and the ...

The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care ...